DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS The advancements have led to significant strides in managing diseases like diabetic retinopathy, macular edema, and age-related macular degeneration.
In the quest to understand and manage ocular diseases, the role of advanced retinal imaging and visual function studies is becoming increasingly significant.
Key Points:
- The article discusses the advancements in retinal imaging and visual function studies and their impact on patient management and understanding disease mechanisms.
- It emphasizes the importance of patient-based research in elucidating disease mechanisms.
- The article highlights the role of advanced retinal imaging in revealing unseen pathological changes, which were previously undetectable with existing clinical examination.
- The article also points out that contrary to initial thinking, sight-threatening damage in diabetes occurs to the outer retina and not only to the inner retina.
Additional Points:
- The research combines sample instrumentation from the author’s laboratory and progress in the fields of retinal imaging and visual function.
- The research was conducted at the University of Pittsburgh School of Medicine, the Schepens Eye Research Harvard Medical School, and the Indiana University School of Optometry from 1979 to the present.
Conclusion:
- The advancements in retinal imaging and visual function studies have not only improved patient management but also provided a deeper understanding of disease mechanisms. These advancements have the potential to revolutionize the way we approach and treat ocular diseases.
Endocrinology Latest Posts
- What to Know About Ozempic Microdosing
- How to Increase Estrogen Naturally
- Lipid Panels Lie: ‘It’s Time to Rethink the Way We Evaluate CV Risk—Before It’s Too Late’
- Eli Lilly Lowers Cost of Zepbound Vials to Attract People Without Insurance Coverage
“…accurate measurement of visual function will lead to decreased variability and costs for clinical trials, by taking into account the optics of the aging eye, retinal location, fixation stability, and pupil size.”
Ann E. Elsner, PhD
School of Optometry
Indiana University
Bloomington, Indiana